Zug, Switzerland
July 03, 2018
:
Shire plc,global biotech leader in rare diseases has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending
Our Bureau, Bengaluru
June 22, 2018
:
AstraZeneca Pharma India has received an import & market permission for durvalumab (Imfinzi) from the Drug Controller General of India (DCGI). The receipt of this permission paves way for the launch of
Shanghai, China
June 21, 2018
:
Pacira Pharmaceuticals, Inc and Nuance Biotech Co. Ltd have entered into an agreement to advance the development and commercialization of Exparel (bupivacaine liposome injectable suspension) in China. Exparel is
Darmstadt, Germany
June 21, 2018
:
Merck, a leading science and technology company, has entered into an agreement with HistoCyte Laboratories Ltd, Tyne, UK, to be the exclusive multinational distributor of the company’s portfolio of cell line reference products for immunohistochemistry and in situ hybridization.
Uppsala, Sweden
June 20, 2018
:
Orexo AB announces that its partner Mundipharma has initiated the launch of Zubsolv (buprenorphine and naloxone sublingual tablet), for use in the treatment of opioid dependence, in the EU.
Our Bureau, Mumbai
June 20, 2018
:
Zydus Cadila has received the tentative approval from the US FDA to market Tadalafil tablets USP, 2.5 mg, 5 mg, 10 mg and 20 mg. It is used to treat erectile dysfunction (impotence) and symptoms of benign prostatic hypertrophy
Hertfordshire, England
June 20, 2018
:
Global pharmaceutical company Mylan N.V. has announced the US launch of bivalirudin for injection, 250 mg single-dose vial, a generic version of Angiomax from The Medicines Company.
Our Bureau, Mumbai
June 19, 2018
:
Dr Reddy’s Laboratories Ltd. has launched levetiracetam in sodium chloride injection, 500 mg/100 mL (5 mg/mL), 1,000 mg/100 mL (10 mg/mL), and 1,500 mg/100 mL (15 mg/mL) single-dose infusion bags, a therapeutic equivalent generic version
Tokyo, Japan
June 16, 2018
:
Daiichi Sankyo Company, Limited (Daiichi Sankyo) announced that it has launched Fentanyl Citrate Tape for 1day “Daiichi Sankyo” (1, 2, 4, 6, and 8 mg dosages; date of marketing approval: February 15, 2018; date of listing
Our Bureau, Mumbai
June 15, 2018
:
Dr. Reddy’s Laboratories has received final approval from the US FDA and is launching buprenorphine and naloxone sublingual film, 2 mg/0.5 mg, 4 mg/1 mg, 8 mg/2 mg, and 12 mg/3 mg, a therapeutic equivalent generic version